Ardent Health (ARDT) Expected to Announce Earnings on Tuesday

Key Points

• Ardent Health (ARDT) is expected to announce its Q2 2025 earnings on August 5th, with analysts predicting earnings of $0.51 per share and revenue of $1.54 billion.
• The company previously reported earnings of $0.29 EPS in Q1, surpassing estimates, and has set its FY 2025 guidance for EPS between 1.730-2.010.
• Analysts have a consensus rating of "Moderate Buy" for Ardent Health, with a target price of $20.30, despite recent downgrades by some institutions.

Ardent Health (NYSE:ARDT - Get Free Report) is expected to be posting its Q2 2025 quarterly earnings results before the market opens on Tuesday, August 5th. Analysts expect Ardent Health to post earnings of $0.51 per share and revenue of $1.54 billion for the quarter. Ardent Health has set its FY 2025 guidance at 1.730-2.010 EPS.

Ardent Health (NYSE:ARDT - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.08. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. Ardent Health had a return on equity of 16.07% and a net margin of 3.73%. On average, analysts expect Ardent Health to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Ardent Health Stock Down 3.7%

Ardent Health stock traded down $0.39 during midday trading on Friday, hitting $10.21. The stock had a trading volume of 470,053 shares, compared to its average volume of 470,005. The company has a current ratio of 2.12, a quick ratio of 1.98 and a debt-to-equity ratio of 0.70. The stock has a market cap of $1.46 billion and a P/E ratio of 6.26. Ardent Health has a 12 month low of $10.10 and a 12 month high of $20.72. The business has a fifty day moving average price of $13.04 and a 200 day moving average price of $13.58.

Wall Street Analyst Weigh In

ARDT has been the subject of several research analyst reports. Bank of America lowered Ardent Health from a "neutral" rating to an "underperform" rating and lowered their price objective for the company from $15.50 to $14.60 in a report on Wednesday, July 16th. Royal Bank Of Canada reissued an "outperform" rating and issued a $21.00 price objective on shares of Ardent Health in a report on Thursday, May 15th. Stephens reaffirmed an "overweight" rating and set a $21.00 target price on shares of Ardent Health in a report on Tuesday, May 20th. Mizuho lowered their target price on Ardent Health from $19.00 to $18.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Finally, Wall Street Zen lowered Ardent Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, July 12th. One analyst has rated the stock with a sell rating, one has given a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, Ardent Health has an average rating of "Moderate Buy" and a consensus price target of $20.30.

Hedge Funds Weigh In On Ardent Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Ardent Health by 103.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company's stock worth $194,000 after buying an additional 7,182 shares during the period. Acadian Asset Management LLC lifted its position in Ardent Health by 574.9% in the first quarter. Acadian Asset Management LLC now owns 40,238 shares of the company's stock worth $550,000 after purchasing an additional 34,276 shares during the period. Jane Street Group LLC lifted its position in Ardent Health by 235.1% in the first quarter. Jane Street Group LLC now owns 57,468 shares of the company's stock worth $790,000 after purchasing an additional 40,318 shares during the period. Finally, Goldman Sachs Group Inc. lifted its position in Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company's stock worth $10,558,000 after purchasing an additional 724,841 shares during the period.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.